文献速递生殖医学

排卵诱导/卵巢刺激的个体化医学方法:基于Ⅰ级证据构建预测模型与在线计算器

A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence.
PubMed 文献 · Fertil Steril · 2022-01-01

本文对两项多中心随机临床试验进行二次分析,纳入750例多囊卵巢综合征女性和900例不明原因不孕女性,构建预测排卵诱导/卵巢刺激周期临床妊娠与多胎妊娠概率的模型,并开发在线计算器。模型对临床妊娠的预测能力为一般,对多胎妊娠的预测能力为良好至优秀。

要点

  • 年龄较轻、体质指数较低、用药剂量与治疗类型与临床妊娠相关。
  • 促性腺激素使用与多胎妊娠相关,且比值比随周期1至4逐渐升高。
  • 模型对多胎妊娠的预测能力良好至优秀,对临床妊娠为一般。

核心结论

  • 作者利用多数已知可预测排卵诱导/卵巢刺激周期结局的因素,构建了易于使用的公式,可预测常用助孕治疗的个体化临床妊娠与多胎妊娠机会,并提供了在线计算器。

研究设计与样本

  • 对两项多中心随机临床试验进行二次分析(合并分析),共纳入750例多囊卵巢综合征女性和900例不明原因不孕女性。
  • 干预为排卵诱导/卵巢刺激,多囊卵巢综合征患者采用定时 intercourse,不明原因不孕患者采用宫腔内人工授精。

主要发现

  • 较年轻的患者年龄和伴侣年龄、治疗类型、较低的体质指数和用药剂量均与临床妊娠相关。
  • 与多胎妊娠相关的变量包括上述变量(年龄除外),以及诊断、产次、较高的窦卵泡计数、抗苗勒管激素水平和卵巢反应。
  • 促性腺激素使用与多胎妊娠相关,比值比在周期1至4逐渐升高。
  • 受试者工作特征曲线显示,模型对临床妊娠的预测能力为一般:曲线下面积(95%CI)第1周期为0.78(0.75-0.81),第4周期为0.70(0.64-0.75)。
  • 模型对多胎妊娠的预测能力为良好至优秀:曲线下面积(95%CI)第1周期为0.78(0.72-0.84),第4周期为0.86(0.78-0.93)。

关键数值与推荐

  • 与累积妊娠率相关的因素包括伴侣年龄、较低的用药剂量、产次、抗苗勒管激素水平和诊断。
  • 临床试验注册号:Assessing Multiple Intrauterine Gestations after Ovulation Stimulation NCT01044862;PPCOSII NCT00719186。

临床怎么用

  • 作者构建的在线计算器(https://pregnancyprediction.medicine.yale.edu/CalDirect.html)可用于预测常用助孕治疗的个体化临床妊娠和多胎妊娠机会。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the probability of clinical or multiple pregnancy during ovulation induction (OI)/ovarian stimulation (OS). DESIGN: Secondary analysis of two multicenter randomized clinical trials (combined). SETTING: Multicenter. PATIENTS: A total of 750 women with polycystic ovary syndrome and 900 women with unexplained infertility. INTERVENTIONS: Ovulation induction/OS with either timed intercourse (polycystic ovary syndrome) or intrauterine insemination. MAIN OUTCOME MEASURES: Clinical and multiple pregnancy rates/cycle, cumulative pregnancy rates. Age, body mass index, parity, diagnosis, medication, markers of ovarian reserve, and ovarian response were considered in multivariable regression models for clinical, multiple, and cumulative pregnancy rates. Receiver operating characteristic curves were created for clinical and multiple pregnancy rates. RESULTS: Younger patient and partner age, treatment type, lower body mass index, and medication dose were all associated with clinical pregnancy. Variables associated with multiple pregnancy included the abovementioned variables (except age), in addition to diagnosis, parity, higher antral follicle count, antimüllerian hormone levels, and ovarian response. Gonadotropin use was associated with multiple pregnancy, with progressively increasing odds ratios (cycles 1-4). Receiver operating characteristic curves indicated the model's predictive power to be fair for clinical pregnancy (areas under the curve [95% confidence interval {CI}]: 0.78 [0.75-0.81] for cycle 1 and 0.70 [0.64-0.75] for cycle 4) and good-to-excellent for multiple pregnancy (areas under the curve [95% CI]: 0.78 [0.72-0.84] for cycle 1 and 0.86 [0.78-0.93] for cycle 4). Partner age, lower medication dose, parity, antimüllerian hormone levels, and diagnosis were associated with cumulative pregnancy rates. CONCLUSIONS: Using the majority of the factors known to predict the outcome of OI/OS cycles, we constructed an easy-to-use formula that may predict individualized chances of clinical and multiple pregnancy for commonly used fertility treatments (https://pregnancyprediction.medicine.yale.edu/CalDirect.html). CLINICAL TRIAL REGISTRATION NUMBERS: Assessing Multiple Intrauterine Gestations after Ovulation Stimulation NCT01044862; PPCOSII NCT00719186.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Souter I, Sun F, Zhang H, et al. A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence. Fertil Steril. 2022. PMID: 35125179. doi:10.1016/j.fertnstert.2021.10.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。